SREBF1 and prostate cancer: As a key regulator in the metabolism of glucose, cholesterol, lipid, and carbohydrate, the first evidence suggestive of LXR involvement in cancer came from studies demonstrating upregulation of LXR target gene sterol response element‐binding protein 1c (SREBP1c) in prostate cancer [30, 31].